Increased mRNA translation delays tumour initiation and exposes a therapeutic vulnerability in lung cancer.

Pardo L, Moore M, Deshmukh R, Powley I, Waldron JA, Kruspig B, McGarry L, Dolma L, Campos AV, Wood C, Leslie H, Hughes M, Jeldes E, Munro J, Mitchell L, Officer-Jones L, Baird R, Coquelet H, Jamieson NB, Sumpton D, Strathdee D, le Quesne J, Bushell M, Murphy DJ, Norman JC

Open source

DOI: 10.1186/s12943-026-02680-z
Published: 2026 May 21
Container: Molecular cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12943-026-02680-z,
  title = {Increased mRNA translation delays tumour initiation and exposes a therapeutic vulnerability in lung cancer.},
  author = {Pardo L and Moore M and Deshmukh R and Powley I and Waldron JA and Kruspig B and McGarry L and Dolma L and Campos AV and Wood C and Leslie H and Hughes M and Jeldes E and Munro J and Mitchell L and Officer-Jones L and Baird R and Coquelet H and Jamieson NB and Sumpton D and Strathdee D and le Quesne J and Bushell M and Murphy DJ and Norman JC},
  year = {2026},
  journal = {Molecular cancer},
  doi = {10.1186/s12943-026-02680-z},
  url = {https://doi.org/10.1186/s12943-026-02680-z}
}

RIS

TY  - JOUR
TI  - Increased mRNA translation delays tumour initiation and exposes a therapeutic vulnerability in lung cancer.
AU  - Pardo L
AU  - Moore M
AU  - Deshmukh R
AU  - Powley I
AU  - Waldron JA
AU  - Kruspig B
AU  - McGarry L
AU  - Dolma L
AU  - Campos AV
AU  - Wood C
AU  - Leslie H
AU  - Hughes M
AU  - Jeldes E
AU  - Munro J
AU  - Mitchell L
AU  - Officer-Jones L
AU  - Baird R
AU  - Coquelet H
AU  - Jamieson NB
AU  - Sumpton D
AU  - Strathdee D
AU  - le Quesne J
AU  - Bushell M
AU  - Murphy DJ
AU  - Norman JC
PY  - 2026
JO  - Molecular cancer
DO  - 10.1186/s12943-026-02680-z
UR  - https://doi.org/10.1186/s12943-026-02680-z
ER  -

APA

L, P., M, M., R, D., I, P., JA, W., B, K., L, M., L, D., AV, C., C, W., H, L., M, H., E, J., J, M., L, M., L, O., R, B., H, C., NB, J., D, S., D, S., J, L. Q., M, B., DJ, M., & JC, N. (2026). Increased mRNA translation delays tumour initiation and exposes a therapeutic vulnerability in lung cancer.. Molecular cancer. https://doi.org/10.1186/s12943-026-02680-z

Source records

pubmed · retrieved 2026-11-10T14:55:38.342Z